BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32632728)

  • 1. Younger Age Is Associated with Improved Survival in Patients Undergoing Liver Transplantation Alone for Metastatic Neuroendocrine Tumors.
    Valvi D; Mei X; Gupta M; Shah MB; Ancheta A; Marti F; Gedaly R
    J Gastrointest Surg; 2021 Jun; 25(6):1487-1493. PubMed ID: 32632728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database.
    Gedaly R; Daily MF; Davenport D; McHugh PP; Koch A; Angulo P; Hundley JC
    Arch Surg; 2011 Aug; 146(8):953-8. PubMed ID: 21844436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for unresectable neuroendocrine tumor liver metastases.
    Rossi RE; Burroughs AK; Caplin ME
    Ann Surg Oncol; 2014 Jul; 21(7):2398-405. PubMed ID: 24562931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.
    Le Treut YP; Grégoire E; Klempnauer J; Belghiti J; Jouve E; Lerut J; Castaing D; Soubrane O; Boillot O; Mantion G; Homayounfar K; Bustamante M; Azoulay D; Wolf P; Krawczyk M; Pascher A; Suc B; Chiche L; de Urbina JO; Mejzlik V; Pascual M; Lodge JP; Gruttadauria S; Paye F; Pruvot FR; Thorban S; Foss A; Adam R;
    Ann Surg; 2013 May; 257(5):807-15. PubMed ID: 23532105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes following liver transplantation for metastatic neuroendocrine tumors.
    Grąt M; Remiszewski P; Smoter P; Wronka KM; Grąt K; Lewandowski Z; Koperski L; Górnicka B; Pacho R; Zborowska H; Patkowski W; Krawczyk M
    Transplant Proc; 2014 Oct; 46(8):2766-9. PubMed ID: 25380913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review.
    Bonaccorsi-Riani E; Apestegui C; Jouret-Mourin A; Sempoux C; Goffette P; Ciccarelli O; Borbath I; Hubert C; Gigot JF; Hassoun Z; Lerut J
    Transpl Int; 2010 Jul; 23(7):668-78. PubMed ID: 20478000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors.
    Sposito C; Rossi RE; Monteleone M; Coppa J; Bongini M; Milione M; Bhoori S; Mazzaferro V
    Transplantation; 2021 Dec; 105(12):2579-2586. PubMed ID: 33908381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for metastatic neuroendocrine tumors.
    Lang H; Oldhafer KJ; Weimann A; Schlitt HJ; Scheumann GF; Flemming P; Ringe B; Pichlmayr R
    Ann Surg; 1997 Apr; 225(4):347-54. PubMed ID: 9114792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for neuroendocrine tumors.
    Florman S; Toure B; Kim L; Gondolesi G; Roayaie S; Krieger N; Fishbein T; Emre S; Miller C; Schwartz M
    J Gastrointest Surg; 2004 Feb; 8(2):208-12. PubMed ID: 15036197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Long-Term Outcomes After Liver Transplantation for Unresectable Metastatic Neuroendocrine Tumors.
    Kuncewicz M; Jaszczyszyn IP; Karaban K; Rykowski P; Krasnodębski M; Morawski M; Kruk E; Koperski Ł; Zieniewicz K; Krawczyk M; Grąt M
    Ann Transplant; 2023 Nov; 28():e941212. PubMed ID: 37986542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Transplant for Metastatic Neuroendocrine Tumors: A Single-Center Experience in Hungary.
    Korda D; Doros A; Piros L; Gerlei Z; Haboub-Sandil A; Mándli T; Fazakas J; Deák ÁP; Máthé Z
    Transplant Proc; 2019 May; 51(4):1251-1253. PubMed ID: 31101208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation in patients with liver metastases from neuroendocrine tumors.
    Spolverato G; Bagante F; Tsilimigras DI; Pawlik TM
    Minerva Chir; 2019 Oct; 74(5):399-406. PubMed ID: 31280548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic surgery for metastases from neuroendocrine tumors.
    Sarmiento JM; Que FG
    Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.
    Nobel YR; Goldberg DS
    Transplantation; 2015 Nov; 99(11):2341-6. PubMed ID: 25989503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
    Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
    Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
    Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
    Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors.
    Mazzaferro V; Sposito C; Coppa J; Miceli R; Bhoori S; Bongini M; Camerini T; Milione M; Regalia E; Spreafico C; Gangeri L; Buzzoni R; de Braud FG; De Feo T; Mariani L
    Am J Transplant; 2016 Oct; 16(10):2892-2902. PubMed ID: 27134017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for metastatic neuroendocrine tumors: Outcomes and prognostic variables.
    Sher LS; Levi DM; Wecsler JS; Lo M; Petrovic LM; Groshen S; Ji L; Uso TD; Tector AJ; Hamilton AS; Marsh JW; Schwartz ME
    J Surg Oncol; 2015 Aug; 112(2):125-32. PubMed ID: 26171686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).
    Vinayak R; Cruz RJ; Ranganathan S; Mohanka R; Mazariegos G; Soltys K; Bond G; Tadros S; Humar A; Marsh JW; Selby RR; Reyes J; Sun Q; Haberman K; Sindhi R
    Liver Transpl; 2017 Dec; 23(12):1577-1588. PubMed ID: 28834194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.
    Rosenau J; Bahr MJ; von Wasielewski R; Mengel M; Schmidt HH; Nashan B; Lang H; Klempnauer J; Manns MP; Boeker KH
    Transplantation; 2002 Feb; 73(3):386-94. PubMed ID: 11884935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.